fda ban compounded tirzepatide New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our FDA Ban on Compounded GLP-1

Lower BMI Many shift from obese to overweight or even healthy ranges

Please consult your doctor for guidance on the medications that may be appropriate for you

The Medicare GLP-1 Bridge is a temporary nationwide program that lets eligible people with Medicare prescription drug coverage buy certain GLP-1 weight-loss medications for a flat $50 monthly copay, no matter what their income level is

Searching Ozempic next to a telehealth program is really a question about semaglutide and how it is sourced

Long-running clinical trials of its active ingredient (semaglutide) have shown it can help people with diabetes regulate blood sugar, feel fuller with smaller portions, decrease appetite, and aid in weight loss

Intracerebral haemorrhage expansion: definitions, predictors, and prevention